🇺🇸 FDA
Patent

US 10233450

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

granted A61PA61P1/04A61P1/16

Quick answer

US patent 10233450 (Methods and compositions for the specific inhibition of gene expression by double-stranded RNA) held by INTEGRATED DNA TECHNOLOGIES, INC. expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
INTEGRATED DNA TECHNOLOGIES, INC.
Grant date
Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61P, A61P1/04, A61P1/16, A61P11/06, A61P17/00